TE
Tema ETFs Portfolio holdings
AUM
$377M
This Quarter Return
-2.81%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$335M
AUM Growth
+$335M
(+39%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
31.69%
Top 10 Holdings %
Top 10 Hldgs %
28.51%
Holding
174
New
26
Increased
81
Reduced
34
Closed
27
Top Buys
| 1 |
Terex
TEX
|
$5.48M |
| 2 |
Herc Holdings
HRI
|
$4.98M |
| 3 |
Bristol-Myers Squibb
BMY
|
$4.58M |
| 4 |
Timken Company
TKR
|
$4.49M |
| 5 |
Eli Lilly
LLY
|
$4.13M |
Top Sells
| 1 |
Primoris Services
PRIM
|
$7.13M |
| 2 |
Fluor
FLR
|
$5.32M |
| 3 |
Federal Signal
FSS
|
$5.11M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$2.66M |
| 5 |
Ascendis Pharma
ASND
|
$2.02M |
Sector Composition
| 1 | Industrials | 43.38% |
| 2 | Healthcare | 33.02% |
| 3 | Utilities | 7.31% |
| 4 | Technology | 5.91% |
| 5 | Financials | 4.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
GFL Environmental
GFL
$18.2B
| $2.24M | 0.67% | +46,459 | New | +$2.24M |
|
52
Honeywell
HON
$139B
| $2.1M | 0.63% | +9,906 | New | +$2.1M |
|
53
Fair Isaac
FICO
$36.5B
| $2.09M | 0.62% | 1,133 +612 | +117% | +$1.13M |
|
54
PPL Corp
PPL
$27B
| $2.04M | 0.61% | +56,421 | New | +$2.04M |
|
55
Sherwin-Williams
SHW
$91.2B
| $2.02M | 0.6% | 5,773 +3,420 | +145% | +$1.19M |
|
56
Genmab
GMAB
$15.3B
| $2.01M | 0.6% | 102,749 +43,814 | +74% | +$858K |
|
57
Xcel Energy
XEL
$42.8B
| $1.99M | 0.59% | +28,077 | New | +$1.99M |
|
58
Crinetics Pharmaceuticals
CRNX
$2.92B
| $1.97M | 0.59% | 58,807 +874 | +2% | +$29.3K |
|
59
Amphenol
APH
$133B
| $1.94M | 0.58% | 29,561 +23,793 | +413% | +$1.56M |
|
|
ONC
60
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $1.93M | 0.58% | 7,083 +834 | +13% | +$227K |
|
61
Summit Therapeutics
SMMT
$17.6B
| $1.89M | 0.57% | 98,111 +71,470 | +268% | +$1.38M |
|
62
Intercontinental Exchange
ICE
$101B
| $1.87M | 0.56% | 10,825 +3,397 | +46% | +$586K |
|
63
Arcellx
ACLX
$3.85B
| $1.87M | 0.56% | 28,450 +20,982 | +281% | +$1.38M |
|
|
BPMC
64
DELISTED
Blueprint Medicines
BPMC
| $1.86M | 0.55% | 20,972 -1,502 | -7% | -$133K |
|
65
Boston Scientific
BSX
$156B
| $1.84M | 0.55% | 18,206 -2,288 | -11% | -$231K |
|
66
Legend Biotech
LEGN
$6.41B
| $1.76M | 0.53% | 52,008 +40,646 | +358% | +$1.38M |
|
67
Powell Industries
POWL
$3.21B
| $1.76M | 0.53% | 10,332 +8,316 | +413% | +$1.42M |
|
|
68
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.75M | 0.52% | 6,475 -9,848 | -60% | -$2.66M |
|
69
argenx
ARGX
$43.6B
| $1.73M | 0.52% | 2,922 -1,676 | -36% | -$992K |
|
70
Copart
CPRT
$47.2B
| $1.7M | 0.51% | 30,080 +17,860 | +146% | +$1.01M |
|
71
CME Group
CME
$96B
| $1.7M | 0.51% | 6,400 +3,800 | +146% | +$1.01M |
|
72
Intuit
INTU
$186B
| $1.67M | 0.5% | 2,720 +1,615 | +146% | +$992K |
|
73
MSCI
MSCI
$43.9B
| $1.64M | 0.49% | 2,901 +1,710 | +144% | +$967K |
|
74
Vertiv
VRT
$48.7B
| $1.64M | 0.49% | 22,673 +18,249 | +413% | +$1.32M |
|
|
MREO
75
Mereo BioPharma
MREO
$272M
| $1.47M | 0.44% | 654,666 -235,882 | -26% | -$531K |
|